BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 34230999)

  • 21. Parathyroid-hormone-related peptide in hematologic malignancies.
    Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
    Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
    Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
    BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful Treatment for Hypercalcemia due to Cosecretion of Parathyroid Hormone-Related Protein and 1,25-Dihydroxyvitamin D
    Ogawa T; Miyata J; Fukunaga K; Kawana A; Inoue T
    Case Rep Pulmonol; 2020; 2020():2475725. PubMed ID: 31976112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin D.
    Zhu V; de Las Morenas A; Janicek M; Hartshorn K
    J Gastrointest Oncol; 2014 Aug; 5(4):E84-7. PubMed ID: 25083313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia.
    Nakayama K; Fukumoto S; Takeda S; Takeuchi Y; Ishikawa T; Miura M; Hata K; Hane M; Tamura Y; Tanaka Y; Kitaoka M; Obara T; Ogata E; Matsumoto T
    J Clin Endocrinol Metab; 1996 Feb; 81(2):607-11. PubMed ID: 8636276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal synthesis of 1,25-dihydroxyvitamin D in patients with malignant lymphoma.
    Davies M; Hayes ME; Yin JA; Berry JL; Mawer EB
    J Clin Endocrinol Metab; 1994 May; 78(5):1202-7. PubMed ID: 8175979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resectable bronchogenic carcinoma presenting with hypercalcemia: tumor-associated granulomatous reaction and probable production of 1,25-dihydroxyvitamin D.
    Akai PS; Wong T; Chang-Poon V; Green F; Whitelaw WA; Hanley DA
    Clin Invest Med; 1989 Jun; 12(3):212-6. PubMed ID: 2743640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
    Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
    J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
    Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
    Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging roles for calcium-regulating hormones beyond osteolysis.
    Goltzman D
    Trends Endocrinol Metab; 2010 Aug; 21(8):512-8. PubMed ID: 20605729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
    Tebben PJ; Singh RJ; Kumar R
    Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.